CVI 2020 Webinar Series:Ultimate Aortic Cases
September 17, 2020 – September 17, 2021
This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.
The goal of this activity is to provide participants with knowledge of how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.
- Recall best practice techniques for bicuspid and tricuspid transcatheter aortic valve therapy
- Describe management approaches for challenges that may occur during transcatheter aortic valve therapy
- List criteria for patient selection for transcatheter aortic valve therapy
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.
The CMEsolutions designates this enduring internet activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Start Date - End Date:
September 17, 2020 - September 17, 2021
There is no registration fee for this activity.
- View webinar
- At the end of the webinar, login to: https://online-med-edu.com/cvi2020/webinar/ultimateaortic
- Complete the Evaluation/Credit Request Form
- Download/Print Credit Statement- No requests will be accepted after September 17, 2021
FACULTY AND DISCLOSURES
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.
Guilherme Attizzani, MD
Director, Valve and Structural Heart Disease Intervention, University of Cleveland
Guilherme Attizzani has disclosed the following relevant financial relationships: Medtronic-Consultant.
Vinayat Bapat, FRCS, CTh
Assistant Professor, Columbia University Medical Center
New York, NY
Vinayat Bapat has disclosed the following relevant financial relationships: 4C, Admedus, Boston Scientific, Medtronic-Consultant
Joao Cavalcante, MD
Director, Cardiac MRI and Structural CT Lab, Minneapolis Heart Institute
Joao Cavalcante has disclosed the following relevant financial relationships: Abbot Vascular, Boston Scientific- Consultant; Circle Cardiovascular Imaging-Consultant, Research Grant; Siemens Healthineers-Consultant, Speaker Bureau; Edwards Lifesciences-Research Grant
Susheel Kodali, MD
Director, Heart Valve Center, NYP/Columbia Heart Valve Center, Columbia University Medical Center
New York, NY
Susheel Kodali has no relevant financial relationships to disclose.
Paul Sorajja, MD
Director, Center for Valve and Structural Heart Diseases, Minneapolis Heart Institute at Abbott Northwestern Hospital
Paul Sorajja has disclosed the following relevant financial relationships: Abbott Vascular- Consultant, Research Grant, Speaker Bureau; Admedus, Teleflex; WL Gore-Consultant; Boston Scientific, Edwards Lifesciences; Medtronic- Consultant, Research Grant.
Steven Yakubov, MD, FACC
Medical Director, Ohio Health Research Institute
Steven Yakubov has disclosed the following relevant financial relationships: Boston Scientific-Advisory Board, Consultant; Medtronic-Speaker’s Bureau.
No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.
This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
Commercial Support for this educational activity will be provided by the following:
- Boston Scientific